Category Archives: Emerging Markets

Future Brighter for MNCs in Mexico, Says Report

Despite Mexico’s efforts to improve its regulatory framework and create a better business environment for pharma, the market share of generic drugs still makes it difficult for multinationals to materialize their commercial benefit. However, a new report from Business Monitor forecasts that, in the long term, Mexico’s improving private health insurance sector and potentially significant investment from […]
Also posted in Global, healthcare | Tagged , , | Leave a comment

Digital Education a Key Bridge to Tapping Emerging Markets

In our second Q&A installment previewing next month’s iPharma2014 conference in New York City, we spoke with David Stern, executive VP of global commercial operations with OvaScience. Stern will be presenting on “Going Global – Innovative Tactics to Engage Emerging Markets and Extend the Global Strategy to a Regional Level.” Drawing from his time as […]
Also posted in Global, healthcare, Medical Education, Patient Communication, Strategy | Tagged , , , , | Leave a comment

Outlook “Gloomy” for TB Investment

The approval last year of Johnson & Johnson’s (J&J) treatment for tuberculosis (bedaquiline) — at the time the first TB drug approval in 40 years — “remains an exception to the generally gloomy outlook” for investment in TB R&D, writes Andrew Ward in this week’s Financial Times.
Also posted in Global, Strategy | Tagged , , , , , | Leave a comment

China Supply Chain Progress Still Hampered by Corruption, Pollution, Working Conditions

Supply chains risks in China still include extremely high levels of corruption, environmental pollution issues and slow working conditions reforms, according to new analysis from Sedex.
Also posted in Global, Supply Chain | Tagged , , , | Leave a comment

Weak IP Protection Threatens Asia-Pac Biotech Boom

The Asia-Pacific (APAC) region is experiencing a significant boom in the volume of private equity and venture capital  investments in biotechnology. According to research and consulting firm GlobalData, healthcare private equity investment in APAC increased by 125.8% between 2011 and 2013,  whereas deal activities in Europe and North America decreased by 30.5% and 2.5% between 2012 […]
Also posted in Deals, Global, IP | Tagged , , , | Leave a comment
  • Categories

  • Meta